CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-γ production and increased sensitivity to dexamethasone

Journal of Infectious Diseases

Volumn 177, Issue 2, 1998, Pages 451-454

  Visser, Jeroen ^b   Blauw, Bep ^b   Hinloopen, Boudewijn ^b   Brommer, Emile ^b   Ronald De Kloet, E ^b   Kluft, Cornelis ^b   Nagelkerken, Lex ^a  

^a TNO   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 4;

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL;

EID: 0031883887     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517373     Document Type: Article

References (14)

1. Fukuda K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9.
2. Beam J, Wessely S. Neurobiological aspects of the chronic fatigue syndrome. Eur J Clin Invest 1994;24:79-90.
3. Swanink CMA, Vercoulen JHMM, Bleijenberg G, Fennis JFM, Galema JMD, van der Meer JWM. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med 1995;237:499-506.
4. Demitrack MA, Dale JK, Strauss SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991;73:1224-34.
5. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J. Clin Microbiol 1990;28:1404-10.
6. Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997;175:136-41.
7. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-38.
8. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;7:145-53.
9. Rook GAW, Hernandez-Pando R, Lightman S. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994;15:301-3.
10. Nijhuis EWP, Hinloopen B, van Lier RAW, Nagelkerken L. Differential sensitivity of human naive and memory CD4 T cells for dexamethasone. Int Immunol 1995;7:591-5.
11. Nijhuis EWP, Oostervink F, Hinloopen B, Rozing J, Nagelkerken L. Differences in dexamethasone sensitivity between lymphocytes from patients with Alzheimer's disease and patients with multi-infarct dementia. Brain Behav Immun 1996;10:115-25.
12. Lloyd A, Hickie I, Hickie C, Dwyer J, Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol 1992;87:76-9.
13. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-76.
14. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 inhibits human lymphocyte interferon-γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-8.